Johnson & Johnson Gets FDA Approval For Pancreaze
Pancreaze (pancrelipase) delayed-release capsules are indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Pancreaze is a combination of porcine-derived lipases, proteases,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.